Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-024-02240-3, published online 08 March 2024
In this article a Clarification Statement has been added to the caption of Fig. 3.
It should read: The EBMT supplemental data used in this paper were based on a single overview per year, without incorporating important qualified updates made retrospectively, further to the impact of the COVID-19 pandemic on reporting. This may have resulted in significant under-reporting of HSCTs in the EBMT data.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
On behalf of Saudi Society of Blood & Marrow Transplantation (SSBMT). Correction: Hematopoietic cell transplantation and cell therapy activity landscape survey in the Kingdom of Saudi Arabia; a report from the Saudi Society of Blood and Marrow Transplantation (SSBMT). Bone Marrow Transplant 60, 116 (2025). https://doi.org/10.1038/s41409-024-02450-9
Published:
Issue date:
DOI: https://doi.org/10.1038/s41409-024-02450-9
